Akebia Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
SATTER MUNEER A director
 Common Stock 5,000 $11.56 $57,800
Purchase
BUTLER JOHN P. director, officer: CEO and Pres..
 Common Stock 1,000 $10.31 $10,305
Purchase
SATTER MUNEER A director
 Common Stock 5,000 $11.53 $57,625
Purchase
SATTER MUNEER A director
 Common Stock 5,000 $11.53 $57,625
Option
BUTLER JOHN P. director, officer: CEO and Pres..
 Common Stock 30,500 $0.47 $14,335
Option
BUTLER JOHN P. director, officer: CEO and Pres..
 Stock Option (right to buy) 30,500 $0.47 $14,335
Purchase
NOVARTIS BIOVENTURES LTD 10 percent owner
 Common Stock 182,590 $17 $3,104,030
Purchase
HADAS NICOLE R. officer: SVP, Chief Legal Officer
 Common Stock 3,500 $17 $59,500
Purchase
AMELLO JASON officer: SVP, CFO & Treasurer
 Common Stock 4,000 $17 $68,000
Purchase
BUTLER JOHN P. director, officer: CEO and Pres..
 Common Stock 13,850 $17 $235,450
Purchase
WYZGA MICHAEL S director
 Common Stock 1,500 $17 $25,500
Purchase
SATTER MUNEER A director
 Common Stock 91,295 $17 $1,552,015
Purchase
NOVO A/S 10 percent owner, other: SEE RE..
 COMMON STOCK 182,590 $17 $3,104,030

Showing 150 to 163 of 163 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: